Krystal Biotech Inc (KRYS)

Cash & Equivalents

$427.74M

Quarterly · Period ending: · USD

KRYS logo

KRYS Cash & Equivalents

Latest reported$427.74M
KRYS Quarterly Cash & Equivalents ($1.92M → $427.74M)
High-resolution chart · PNG

KRYS cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
427,740,000
501,313,000
496,304,000
392,604,000
353,829,000
308,770,000
344,865,000
373,966,000
345,786,000
359,006,000
358,328,000
373,241,000
275,875,000
140,745,000
161,900,000
186,409,000
218,720,000
269,303,000
341,246,000
286,614,000
329,527,000
402,172,000
268,269,000
282,369,000
291,678,000
180,225,000
187,514,000
194,806,000
186,587,000
98,013,000
103,670,000
46,667,000
41,813,000
47,228,000
49,591,000
52,570,000
3,518,000
1,959,000
1,923,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.